{"schema_version":"secwatch.filing_event.v1","accession":"0000313616-23-000002","form_type":"8-K","ticker":"DHR","cik":"0000313616","company_name":"DANAHER CORP /DE/","filed_at":"2023-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.585854+00:00","generated_at":"2026-06-20T18:20:56.141891+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Danaher expects Q4 non-GAAP core revenue growth high-single digits, above prior guidance","bullets":["Q4 estimated revenues up low-single-digit% YoY; non-GAAP core revenue growth high-single-digit% vs prior flat to low-single-digit decline guidance.","Base business core revenue growth high-single-digit%, in line with previous guidance.","Cepheid respiratory testing revenue exceeded $1B in Q4.","Full Q4 and FY 2022 earnings call scheduled for Jan 24, 2023 at 8:00 a.m. ET."],"urls":{"canonical":"https://secwatch.observer/filing/0000313616-23-000002","json":"https://secwatch.observer/filing/0000313616-23-000002.json","markdown":"https://secwatch.observer/filing/0000313616-23-000002.md","text":"https://secwatch.observer/filing/0000313616-23-000002.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/313616/000031361623000002/0000313616-23-000002-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/313616/000031361623000002/dhr-20230109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T18:20:56.141891+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b03f09b828b243b4bd311a22a7869683a7bbf252","claim":"DANAHER CORP /DE/ reported fourth quarter 2022 results: revenue increase in the low-single digit percent range year-over-year. Guidance reaffirmed.","evidence_excerpt":"For the fourth quarter 2022, estimated revenues are anticipated to increase in the low-single digit percent range year-over-year.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/313616/000031361623000002/0000313616-23-000002-index.htm","confidence":0.85,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter 2022"},{"label":"Revenue","value":"increase in the low-single digit percent range year-over-year"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}